Source: Xvivo Perfusion AB
Today XVIVO Perfusion is publishing the Annual Report for 2013 (in Swedish). The Annual Report is attached to this press release and will also be available on www.xvivoperfusion.com. A printed version of the Annual report 2013 can be ordered by phone +46 (0)31 788 21 50 or by email firstname.lastname@example.org. April 7, 2014 Gothenburg XVIVO Perfusion AB (publ) For further information please contact: Christoffer Rosenblad, CFO, +46 31 788 21 59, email@example.com For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com XVIVO Perfusion is required to publish the information in this press release in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on April 7, 2014 at 9:30 a.m. This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails. ________________________________________________________________________________ _ _____________________________________ XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in the USA. The Xvivo share is listed on NASDAQ OMX First North and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com. The Certified Adviser is Redeye, www.redeye.se. ________________________________________________________________________________ _ _____________________________________ XVIVO Perfusion AB (publ), Box 53015, SE-400 14 Göteborg. Corporate identity number 556561-0424. Tel: 46 31 788 21 50. Fax: 46 31 788 21 69. E-mail: firstname.lastname@example.org. Website: www.xvivoperfusion.com
Retrieved from "http://globenewswire.com/news-release/2014/04/07/624861/0/en/Annual-report-2013.html"